- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small Cell Lung Cancer NSCLC in Australia
Total 553 results
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
AstraZenecaCompletedNon - Small Cell Lung Cancer NSCLCUnited States, France, Germany, Italy, United Kingdom, Belgium, Poland, Romania, Taiwan, Thailand, Canada, Korea, Republic of, Czechia, Hungary, Japan, Russian Federation, Hong Kong, Spain, Netherlands, Greece, Australia, Serbia, Bu... and more
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Austria, Spain
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Trans Tasman Radiation Oncology GroupCompletedMetastatic Non Small Cell Lung CancerSingapore, Australia
-
Eucure (Beijing) Biopharma Co., LtdWithdrawnHCC | NSCLC Stage IV | NSCLC Stage IIIBChina, Australia, Taiwan, Armenia, Austria
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Medical University of ViennaUnknownNon Small Cell Lung CancerAustria
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Olivia Newton-John Cancer Research InstituteMerck Sharp & Dohme LLC; ViralyticsActive, not recruiting
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
AmgenRecruitingMTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid TumorsUnited States, Australia, Canada
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompleted
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung Carcinoma NSCLCUnited States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
-
Hoffmann-La RocheTerminatedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Belgium, Germany, Spain, Australia, Canada, United Kingdom, France, Poland, Ireland
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Belgium, France, Italy, Spain, Brazil, Australia, Germany, Turkey, Mexico, United States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerAustralia
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustria
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Turkey
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain